April 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
Market insights predict, the drug-device combination products industry is expected to grow from USD 161.78 billion in 2024 to USD 337.81 billion by 2034, driven by a CAGR of 7.64%. The rising incidences of chronic disorders, demand for personalized medicines, and favorable government policies drive the market....
April 21, 2026
According to market projections, the blood product sector is expected to grow from USD 39.96 billion in 2025 to USD 62.65 billion by 2035, reflecting a CAGR of 4.6%, driven by rising demand in surgeries, cancer care, and trauma cases. North America leads in revenue, while Asia-Pacific shows the fastest growth. RBCs and blood stations dominate the m...
April 21, 2026
According to market estimations, the global thrombopoietin receptor agonists industry, valued at US$ 1.85 billion in 2023, is set to reach US$ 3.74 billion by 2034, driven by rising platelet-related disorders like ITP and AML. Key trends include FDA approvals, growing R&D, and increasing use in hospitals. North America leads, while Asia-Pacif...
April 21, 2026
North America dominated the human blood products market, fueled by regular donation drives, widespread facilities and government efforts to improve blood storage and awareness. In the U.S., 6.8 million people donate annually, while 52% of Canadians have needed blood or blood products....
April 21, 2026
Based on market forecasts, the nebulizer devices sector will expand from USD 1.23 billion in 2024 to USD 2.2 billion by 2034, experiencing a CAGR of 5.94%. The rising incidences of chronic respiratory disorders, advancements in medical devices, and increasing investments drive the market....
April 21, 2026
According to market forecast, the global oral thrombopoietin receptor agonists market is projected to reach US$ 9.95 billion by 2034, driven by rising cases of thrombocytopenia and advancements in TPO-RAs. North America leads, while Asia-Pacific shows strong growth potential. Key players include Novartis, Sobi, and Shionogi....
April 21, 2026
The in-ear hearing aids market was dominated by the ITE-half shell segment, known for its comfort and effectiveness in treating mild-to-moderate hearing loss. The ITE-full shell segment is expected to grow significantly, offering more amplification for moderate-to-severe cases. Additionally, age-related hearing loss is the leading application, driv...
April 21, 2026
Eltrombopag Drugs Market: In October 2024, Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Company Limited gained approval from China's National Medical Products Administration to market Eltrombopag Olamine tablets. Additionally, in November 2023, the U.S. FDA authorized Teva's Alvaiz (eltrombopag) tablets for treating thrombocytopenia in adults...
April 21, 2026
Polymerase chain reaction (PCR) is a DNA amplification method widely used in diagnostics and biotechnology. In 2022, India conducted 600-700 million diagnostic tests, adding 1,390 biotech startups. PCR enzymes drive efficiency and sustainability. The U.S. and UK continue to invest heavily in biotech innovation....
April 21, 2026
The nerve repair and regeneration market grows with rising nerve injuries from accidents, chronic disorders, and trauma. Companies like Progentos and Neuraptive advance treatments, with Axogen reporting growth in surgical solutions for peripheral nerve repair. Innovation drives this expanding field....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com